View in EDS HTML Full Text PDF Full Text

Developments in Combining Targeted Radionuclide Therapies and Immunotherapies for Cancer Treatment.

Saved in:
Bibliographic Details
Title: Developments in Combining Targeted Radionuclide Therapies and Immunotherapies for Cancer Treatment.
Authors: Kerr CP; Department of Radiology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53705, USA.; Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53705, USA., Grudzinski JJ; Department of Radiology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53705, USA., Nguyen TP; Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53705, USA., Hernandez R; Department of Medical Physics, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53705, USA., Weichert JP; Department of Radiology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53705, USA., Morris ZS; Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53705, USA.
Source: Pharmaceutics [Pharmaceutics] 2022 Dec 30; Vol. 15 (1). Date of Electronic Publication: 2022 Dec 30.
Publication Type: Journal Article; Review
Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101534003 Publication Model: Electronic Cited Medium: Print ISSN: 1999-4923 (Print) Linking ISSN: 19994923 NLM ISO Abbreviation: Pharmaceutics Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36678756
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Developments in Combining Targeted Radionuclide Therapies and Immunotherapies for Cancer Treatment.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Kerr+CP%22">Kerr CP</searchLink>; Department of Radiology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53705, USA.; Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53705, USA.<br /><searchLink fieldCode="AU" term="%22Grudzinski+JJ%22">Grudzinski JJ</searchLink>; Department of Radiology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53705, USA.<br /><searchLink fieldCode="AU" term="%22Nguyen+TP%22">Nguyen TP</searchLink>; Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53705, USA.<br /><searchLink fieldCode="AU" term="%22Hernandez+R%22">Hernandez R</searchLink>; Department of Medical Physics, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53705, USA.<br /><searchLink fieldCode="AU" term="%22Weichert+JP%22">Weichert JP</searchLink>; Department of Radiology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53705, USA.<br /><searchLink fieldCode="AU" term="%22Morris+ZS%22">Morris ZS</searchLink>; Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53705, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101534003%22">Pharmaceutics</searchLink> [Pharmaceutics] 2022 Dec 30; Vol. 15 (1). <i>Date of Electronic Publication: </i>2022 Dec 30.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22MDPI%22">MDPI </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101534003 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>1999-4923 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219994923%22">19994923 </searchLink><i>NLM ISO Abbreviation: </i>Pharmaceutics <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36678756
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3390/pharmaceutics15010128
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Developments in Combining Targeted Radionuclide Therapies and Immunotherapies for Cancer Treatment.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kerr CP
      – PersonEntity:
          Name:
            NameFull: Grudzinski JJ
      – PersonEntity:
          Name:
            NameFull: Nguyen TP
      – PersonEntity:
          Name:
            NameFull: Hernandez R
      – PersonEntity:
          Name:
            NameFull: Weichert JP
      – PersonEntity:
          Name:
            NameFull: Morris ZS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 30
              M: 12
              Text: 2022 Dec 30
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-print
              Value: 1999-4923
          Numbering:
            – Type: volume
              Value: 15
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Pharmaceutics
              Type: main
ResultId 1